Skip to main content
. 2013 Dec 7;5(2):363–374. doi: 10.18632/oncotarget.1620

Figure 4. RO4929097 and TMZ treatment of glioblastoma cells in vitro.

Figure 4

A, cell viability analysis of U87-WT and U87-R1 cells four days after treatment with RO4929097 (30 μM) and TMZ (100 μM). B, similar as A for a panel of primary glioblastoma cell lines. C, MGMT methylation status and MGMT protein expression of the individual primary glioblastoma cell lines used in B. Shown are averages, error bars indicate SD. *p<0.05 t test.